Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hyd...
Gespeichert in:
Veröffentlicht in: | European journal of pediatrics 1991-07, Vol.150 (9), p.665-668 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 668 |
---|---|
container_issue | 9 |
container_start_page | 665 |
container_title | European journal of pediatrics |
container_volume | 150 |
creator | WALKA, M. M DAUMLING, S HADORN, H.-B KRUSE, K BELOHRADSKY, B. H |
description | We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets. |
doi_str_mv | 10.1007/BF02072630 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72123147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72123147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</originalsourceid><addsrcrecordid>eNpFkEtLxDAURoMo4zi6cS9kIS6E6k2aNOlSR0cHRtyo25LmgdE2rU2L9N9bmUFXd_EdDpeD0CmBKwIgrm9XQEHQLIU9NCcspQkBke2jOaQMkozk-SE6ivEDJjgncoZmJOOcZXSOnt58r2of8B02trXB2NDjzutP20fcj63F6zX-9v07rkdbNc6XXRN9xCoY7Ot6CBabMboh6N434RgdOFVFe7K7C_S6un9ZPiab54f18maT6JSQPqECBBDLwIJjCoARQWXpXEYZpSWlhBrDcihlKjPKpTHCMW4lByUzaTRNF-hi62275muwsS9qH7WtKhVsM8RCTIqUMDGBl1tQT2_Hzrqi7XyturEgUPy2K_7bTfDZzjqUtTX_6DbWtJ_vdhW1qlyngvbxD-OUcU4g_QEWfHQX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72123147</pqid></control><display><type>article</type><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</creator><creatorcontrib>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</creatorcontrib><description>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/BF02072630</identifier><identifier>PMID: 1655462</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Biological and medical sciences ; Calcium - therapeutic use ; Chemotaxis, Leukocyte ; Diseases of the osteoarticular system ; Humans ; Hypophosphatemia, Familial - complications ; Hypophosphatemia, Familial - drug therapy ; Hypophosphatemia, Familial - immunology ; Immunoglobulin G - analysis ; Immunoglobulin M - analysis ; Infant ; Infusions, Intravenous ; Male ; Malformations and congenital and or hereditary diseases involving bones. Joint deformations ; Medical sciences ; Neutrophils - physiology ; Primary Myelofibrosis - complications</subject><ispartof>European journal of pediatrics, 1991-07, Vol.150 (9), p.665-668</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</citedby><cites>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5245510$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1655462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WALKA, M. M</creatorcontrib><creatorcontrib>DAUMLING, S</creatorcontrib><creatorcontrib>HADORN, H.-B</creatorcontrib><creatorcontrib>KRUSE, K</creatorcontrib><creatorcontrib>BELOHRADSKY, B. H</creatorcontrib><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</description><subject>Biological and medical sciences</subject><subject>Calcium - therapeutic use</subject><subject>Chemotaxis, Leukocyte</subject><subject>Diseases of the osteoarticular system</subject><subject>Humans</subject><subject>Hypophosphatemia, Familial - complications</subject><subject>Hypophosphatemia, Familial - drug therapy</subject><subject>Hypophosphatemia, Familial - immunology</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin M - analysis</subject><subject>Infant</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Malformations and congenital and or hereditary diseases involving bones. Joint deformations</subject><subject>Medical sciences</subject><subject>Neutrophils - physiology</subject><subject>Primary Myelofibrosis - complications</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLxDAURoMo4zi6cS9kIS6E6k2aNOlSR0cHRtyo25LmgdE2rU2L9N9bmUFXd_EdDpeD0CmBKwIgrm9XQEHQLIU9NCcspQkBke2jOaQMkozk-SE6ivEDJjgncoZmJOOcZXSOnt58r2of8B02trXB2NDjzutP20fcj63F6zX-9v07rkdbNc6XXRN9xCoY7Ot6CBabMboh6N434RgdOFVFe7K7C_S6un9ZPiab54f18maT6JSQPqECBBDLwIJjCoARQWXpXEYZpSWlhBrDcihlKjPKpTHCMW4lByUzaTRNF-hi62275muwsS9qH7WtKhVsM8RCTIqUMDGBl1tQT2_Hzrqi7XyturEgUPy2K_7bTfDZzjqUtTX_6DbWtJ_vdhW1qlyngvbxD-OUcU4g_QEWfHQX</recordid><startdate>19910701</startdate><enddate>19910701</enddate><creator>WALKA, M. M</creator><creator>DAUMLING, S</creator><creator>HADORN, H.-B</creator><creator>KRUSE, K</creator><creator>BELOHRADSKY, B. H</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910701</creationdate><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><author>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Biological and medical sciences</topic><topic>Calcium - therapeutic use</topic><topic>Chemotaxis, Leukocyte</topic><topic>Diseases of the osteoarticular system</topic><topic>Humans</topic><topic>Hypophosphatemia, Familial - complications</topic><topic>Hypophosphatemia, Familial - drug therapy</topic><topic>Hypophosphatemia, Familial - immunology</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin M - analysis</topic><topic>Infant</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Malformations and congenital and or hereditary diseases involving bones. Joint deformations</topic><topic>Medical sciences</topic><topic>Neutrophils - physiology</topic><topic>Primary Myelofibrosis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WALKA, M. M</creatorcontrib><creatorcontrib>DAUMLING, S</creatorcontrib><creatorcontrib>HADORN, H.-B</creatorcontrib><creatorcontrib>KRUSE, K</creatorcontrib><creatorcontrib>BELOHRADSKY, B. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WALKA, M. M</au><au>DAUMLING, S</au><au>HADORN, H.-B</au><au>KRUSE, K</au><au>BELOHRADSKY, B. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1991-07-01</date><risdate>1991</risdate><volume>150</volume><issue>9</issue><spage>665</spage><epage>668</epage><pages>665-668</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>1655462</pmid><doi>10.1007/BF02072630</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-6199 |
ispartof | European journal of pediatrics, 1991-07, Vol.150 (9), p.665-668 |
issn | 0340-6199 1432-1076 |
language | eng |
recordid | cdi_proquest_miscellaneous_72123147 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Biological and medical sciences Calcium - therapeutic use Chemotaxis, Leukocyte Diseases of the osteoarticular system Humans Hypophosphatemia, Familial - complications Hypophosphatemia, Familial - drug therapy Hypophosphatemia, Familial - immunology Immunoglobulin G - analysis Immunoglobulin M - analysis Infant Infusions, Intravenous Male Malformations and congenital and or hereditary diseases involving bones. Joint deformations Medical sciences Neutrophils - physiology Primary Myelofibrosis - complications |
title | Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20dependent%20rickets%20type%20II%20with%20myelofibrosis%20and%20immune%20dysfunction&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=WALKA,%20M.%20M&rft.date=1991-07-01&rft.volume=150&rft.issue=9&rft.spage=665&rft.epage=668&rft.pages=665-668&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/BF02072630&rft_dat=%3Cproquest_cross%3E72123147%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72123147&rft_id=info:pmid/1655462&rfr_iscdi=true |